Zobrazeno 1 - 10 of 284 pro vyhledávání: '"Funazo, T."'
1
Akademický článek
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.
Autor: Ogimoto T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tsuji T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Anatomy and Molecular Cell Biology, Graduate School of Medicine, Nagoya University, Nagoya, Japan., Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hashimoto K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hosoya K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nomizo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hamaji M; Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Menju T; Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshizawa A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Date H; Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Apr 02; Vol. 23 (4), pp. 564-576.
Zobrazit plný text záznamu
2
Akademický článek
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer.
Autor: Ogimoto T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Nomizo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Hashimoto K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Hosoya K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Tsuji T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.; Department of Anatomy and Molecular Cell Biology, Graduate School of Medicine, Nagoya University, Nagoya, Aichi 466-8550, Japan., Sakamori Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Kuninaga K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Publikováno v: Oncology letters [Oncol Lett] 2023 Jul 10; Vol. 26 (2), pp. 364. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
Autor: Ajimizu H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ozasa H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Sato S; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. ssato@kuhp.kyoto-u.ac.jp., Funazo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Sakamori Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Nomizo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Kuninaga K; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ogimoto T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Hosoya K; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Yamazoe M; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Tsuji T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Itotani R; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ueno K; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Kim YH; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Muro S; Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan., Hirai T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Publikováno v: Scientific reports [Sci Rep] 2023 Feb 06; Vol. 13 (1), pp. 2117. Date of Electronic Publication: 2023 Feb 06.
Zobrazit plný text záznamu
4
Akademický článek
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.
Autor: Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tsuji T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Anatomy and Molecular Cell Biology, Graduate School of Medicine, Nagoya University, Nagoya, Japan., Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hashimoto K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hosoya K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ogimoto T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Itotani R; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Sakamori Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kuninaga K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Aoki W; Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Publikováno v: Cancer science [Cancer Sci] 2023 Feb; Vol. 114 (2), pp. 546-560. Date of Electronic Publication: 2022 Nov 23.
Zobrazit plný text záznamu
5
Akademický článek
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series.
Autor: Hashimoto K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Yoshizawa A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto-shi, Kyoto 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Ogimoto T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Hosoya K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Sakamori Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto-shi, Kyoto 606-8507, Japan.
Publikováno v: Oncology letters [Oncol Lett] 2022 Sep 22; Vol. 24 (5), pp. 402. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
Zobrazit plný text záznamu
6
Akademický článek
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
Autor: Ajimizu H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ozasa H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Sato S; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. ssato@kuhp.kyoto-u.ac.jp., Funazo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Sakamori Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Nomizo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Kuninaga K; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ogimoto T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Hosoya K; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Yamazoe M; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Tsuji T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Yoshida H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Itotani R; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Ueno K; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Kim YH; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan., Muro S; Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan., Hirai T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Publikováno v: Scientific reports [Sci Rep] 2021 Dec 08; Vol. 11 (1), pp. 23677. Date of Electronic Publication: 2021 Dec 08.
Zobrazit plný text záznamu
7
Akademický článek
PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.
Autor: Yoshida H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Nomizo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Ozasa H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan. Electronic address: ozahiro@kuhp.kyoto-u.ac.jp., Tsuji T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Funazo T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Yasuda Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Ajimizu H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Yamazoe M; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Kuninaga K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Ogimoto T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Hosoya K; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Itotani R; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Sakamori Y; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Japan., Kim YH; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan., Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan.
Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Feb; Vol. 144, pp. 317-325. Date of Electronic Publication: 2020 Dec 30.
Zobrazit plný text záznamu
8
Akademický článek
Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model.
Autor: Funazo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Tsuji T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ozasa H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. ozahiro@kuhp.kyoto-u.ac.jp., Furugaki K; Department of Product Research, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, Japan., Yoshimura Y; Department of Product Research, Kamakura Research Laboratories, Chugai Pharmaceutical, Kanagawa, Japan., Oguri T; Department of Education and Research Center for Community Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Ajimizu H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yasuda Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nomizo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sakamori Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Kim YH; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Hirai T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Jun; Vol. 19 (6), pp. 1320-1327. Date of Electronic Publication: 2020 Mar 26.
Zobrazit plný text záznamu
9
Akademický článek
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-X L expression.
Autor: Yasuda Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ozasa H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. ozahiro@kuhp.kyoto-u.ac.jp., Kim YH; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yamazoe M; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ajimizu H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yamamoto Funazo T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nomizo T; Department of Respiratory Medicine, Takatsuki Red Cross Hospital, Takatsuki, Japan., Tsuji T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yoshida H; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sakamori Y; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nakajima N; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Menju T; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yoshizawa A; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Date H; Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Hirai T; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Publikováno v: Cell death & disease [Cell Death Dis] 2020 Mar 09; Vol. 11 (3), pp. 177. Date of Electronic Publication: 2020 Mar 09.
Zobrazit plný text záznamu
10
Akademický článek
Nivolumab in non-small-cell lung cancer with EGFR mutation
Autor: Yoshida, H., Kim, Y.H., Ozasa, H., Nagai, H., Sakamori, Y., Tsuji, T., Nomizo, T., Yasuda, Y., Funazo, T., Hirai, T.
Publikováno v: In Annals of Oncology March 2018 29(3):777-778
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje